Lumentum Holdings Inc. (LITE) fell 22.3% in five days to about $675, despite revenue up 136.5% from a year ago and an all-stock takeover agreement with Marvell Technology. The weekly trend is down and the stock sits 40.5% below its October 6 peak. The balance of evidence for the next two to six weeks leans negative, with high conviction. Strong results have not stopped the selling.
Why it matters
On November 2, 2026, LITE filed two items. The first was a definitive agreement for Marvell to acquire the company in an all-stock deal: 4.500 Marvell shares for each LITE share, an enterprise value of $115 billion and a premium of about 23.9% over the unaffected closing price (SEC EDGAR). The second was fiscal first-quarter 2027 results: revenue of $1.26 billion, up 25.5% from the prior quarter, a non-GAAP gross margin of 53.2%, a non-GAAP operating margin of 42.3% and GAAP net income of $360.3 million (SEC EDGAR). On the numbers alone, that is a business growing fast and a buyer paying a premium.
The market did not respond that way. A target in a premium takeover normally trades close to the offer, but LITE is down 1.43% today, 22.3% over five days and 38.0% over the past month. Because the deal is all-stock, what LITE holders receive moves with Marvell's share price, and the filings listed here do not say where that stands. Nothing in the news explains a drop of this size, so it should be treated as unexplained. Today's volume is 2.1% below its 20-day average, which does not point to a fresh burst of selling.
The decline is mostly the stock's own. Over five days LITE lost 22.3%, against 2.1% for the S&P 500 and 7.1% for the technology sector fund XLK. That leaves the stock 15.3 points behind its sector. Over 50 days it trails the S&P 500 by 25.0 points and XLK by 20.6. The market and the sector explain a small part of the move; the rest is specific to LITE.
No articles in the debate feed argue the case either way, so the argument has to be inferred from the numbers. One side points to results and a takeover premium. The other points to a price that has been falling regardless. Analysts lean toward the first view: 26 of them rate it a buy, with a mean price target of $1,122.38 and a range of $685 to $1,425. The shares trade 39.9% below that mean and below even the lowest target. Either the targets have not caught up with the facts, or the market is pricing something the analysts are not.
What the evidence says
The long-term thesis is weakened, not broken. LITE is up 82.5% this year and stands 258% above its 52-week low of $188.36. But it is below both its 10-week and 40-week averages, and below the 200-day average at $804.63 and the 50-day average at $916.15. It is 6 months down 29.2%. That pattern fits a markdown after a very large run, with the weekly trend now pointing down.
For the next two to six weeks the balance of evidence leans negative, and conviction is high, at 3 of 4 points. The daily trend runs with the weekly downtrend. The stock lags the S&P 500 by 25.0% over 50 days and lags XLK by 20.6%. Price, trend and relative strength all point the same way.
The strongest case against that reading is a mix of valuation and momentum. The RSI is 32.48, close to oversold. The quarter was strong. The price sits below the lowest analyst target, and the deal carries a premium. Oversold readings can persist in a downtrend, though, and an all-stock deal ties the price to another company's shares rather than to LITE's results. That tension is why conviction is 3 of 4 and not higher.
Levels that matter
The structure holds below $700, a round number where sellers have shown up on rallies. Above it sit $750 and the $782.35 swing zone. The weekly downtrend ends only above $804.63, the 200-day average. Below the price, $650 and $600 are the nearest support.
The breakout level is a daily close below $650. From there the math runs to a first target of $402.20, the swing zone, and a second at the 52-week low of $188.36. The level that would make a breakout wrong is $719.33, which is $700 plus a quarter of the 14-day average true range of $77.32. Measured against that stop, the first target gives 3.6 to 1 and the second 6.7 to 1, so the math clears the 3 to 1 threshold.
What would change the picture
A weekly close above $804.63, the 200-day average, would change the picture. The non-price fact that would most likely do it is evidence that the all-stock exchange is anchoring LITE's price, for example shares moving in step with the value of the Marvell offer. That would show the selloff was deal mechanics and not a loss of confidence in the business.
What to watch
- Earnings: the next report is due February 2, 2027. The number that matters is year-over-year revenue growth, which was 136.5% this quarter.
- Sector: XLK is down 7.1% over five days and 11.9% over a month. Moves in technology, and in Marvell's shares given the exchange ratio, can move LITE before any news of its own.
- Valuation: the price is $674.64 against a mean target of $1,122.38 and a lowest target of $685. A close gap to the consensus floor would be a sign that the market has caught up with the analysts.